Search Results for citation:"89 FR 101051"

Found 3 results
Skip to main content

Search Results: citation:"89 FR 101051"

  • Type:Notice
    Citation:89 FR 101051
    Reading Time:about a minute or two

    The National Center for Natural Products Research has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of specific controlled substances. Specifically, they intend to manufacture these substances for product development and reference standards. The controlled substances include drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), which will be isolated from Marihuana Extract (7350), but no cultivation of marihuana is authorized. Interested parties have until February 11, 2025, to submit comments or request a hearing on this application.

    Simple Explanation

    The National Center for Natural Products Research wants to make special substances from marihuana, but they won't grow any plants; they need permission from a group called the DEA to do this, and people can say what they think about this idea until February 11, 2025.

  • Type:Notice
    Citation:89 FR 101051
    Reading Time:about a minute or two

    The Judicial Conference of the United States will hold a hybrid meeting of the Committee on Rules of Practice and Procedure on January 7, 2025, in San Diego, CA. The meeting allows for remote attendance and is open to the public for observation, but attendees cannot participate. Those wishing to attend in person must register by December 31, 2024, while remote observation registrations can be completed until the meeting date. Additional details and materials will be available online at least seven days before the meeting.

    Simple Explanation

    The Judicial Conference is having a meeting where some people can be there in person and others can watch on computers from home on January 7, 2025. If someone wants to go to this meeting, they have to sign up by the end of December 2024, and they can watch from home without signing up until the day of the meeting.

  • Type:Notice
    Citation:89 FR 101051
    Reading Time:about a minute or two

    Groff NA Hemplex LLC has applied to the Drug Enforcement Administration to become a registered importer of certain controlled substances. These substances will be imported in bulk to produce research-grade materials for clinical trial studies, specifically involving Marihuana Extract compounds. The application process allows for public comments or objections and requests for a hearing until January 13, 2025. The comments should be submitted electronically through the Federal eRulemaking Portal, while hearing requests must be directed to the DEA's office in Springfield, Virginia.

    Simple Explanation

    Groff NA Hemplex LLC wants permission to bring special plant extracts from outside the country to use for research. People can tell the government what they think about it until January 13, 2025.